Home > Press > Unidym Appoints Seasoned Finance Executive as Chief Financial Officer
Unidym, Inc., a majority-owned subsidiary of Arrowhead Research Corporation (NASDAQ:ARWR), announced today that Ralph J. Harms has been appointed Chief Financial Officer. Unidym is a leader in the development and manufacture of carbon nanotubes for applications in the electronics industry. Unidym, which recently merged with Carbon Nanotechnologies, Inc. (CNI), possesses a foundational patent portfolio that covers nearly every aspect of carbon nanotube manufacturing and processing.
Unidym Appoints Seasoned Finance Executive as Chief Financial Officer
MENLO PARK, CA | Posted on September 4th, 2007
"Ralph brings to Unidym a wealth of financial management experience, in both private and public technology companies, that will be beneficial to our company and shareholders as we grow," said Art Swift, Unidym's President & CEO. "In addition to considerable experience in capital markets, Ralph has experience in building the infrastructure necessary to successfully deal with the intricacies of technology manufacturing and licensing businesses. Ralph's background is an essential addition to Unidym as we expand our leadership position in carbon nanotube applications, manufacturing and licensing."
"Unidym's carbon nanotube manufacturing capabilities and application technologies hold potential for important applications such as more robust touch screens, lower cost flat panel displays, more efficient thin-film solar cells, and flexible electronics. The company's extensive intellectual property portfolio also offers partnership and licensing opportunities in markets as diverse as life sciences and structural materials," commented Mr. Harms. "I look forward to my role at Unidym as we take the business forward and maximize the company's long-term value to Arrowhead and Unidym's other shareholders."
Ralph has more than 25 years of experience as a financial professional with a strong track record of financial leadership in public and private companies. He comes to Unidym from Transmeta Corporation (NASDAQ:TMTAD), an innovative semiconductor company in the Silicon Valley, where he served as CFO. Prior to Transmeta, Ralph was CFO with a number of high growth technology companies in semiconductors, data networking and telecommunications, software and Internet infrastructure. Ralph has led three successful Nasdaq IPOs for ESS Technology (NASDAQ:ESST), Flycast Communications (NASDAQ:FCST and acquired by CMGI) and Autonomy plc (LSE:AU). He has led seven mergers and acquisition activities and raised public and private financing totaling approximately $1.7 billion during his career. Ralph has also held senior financial management positions at Intel, Rockwell International and Xerox.
Ralph earned a B.S. in Electrical Engineering at Michigan State University and an M.B.A from The University of Michigan. He is also a Director of The CFO Network.
About Unidym, Inc.
Unidym ( http://www.unidym.com ) is a leader in the manufacture and application of carbon nanotubes (CNTs), a novel material with extraordinary electrical, thermal, and mechanical properties. Unidym provides bulk materials, CNT-enabled products, and intellectual property to a wide range of customers and business partners. As a result of its recent merger with CNI, Unidym possesses a foundational patent portfolio that covers nearly every aspect of CNT manufacturing and processing as well as multiple product applications.
Unidym is focused on the electronics industry where its initial products include transparent electrodes for touch screens, flat panel displays, solar cells, and solid state lighting; electrodes for fuel cells; and thin film transistors for printable electronics. Unidym is also pursuing a cross-industry partnership strategy to capture value from the wide ranging uses of CNTs. Unidym’s licensing program, technical expertise and manufacturing facilities can enable partners to rapidly develop CNT solutions for their specific applications.
Unidym is a majority-owned subsidiary of Arrowhead Research Corporation (NASDAQ:ARWR).
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:
This news release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the future success of our scientific studies, our ability to successfully develop products, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions. Arrowhead’s Annual Report on Form 10-K and 10-K/A, recent and forthcoming Quarterly Reports on Form 10-Q and 10-Q/A, recent Current Reports on Forms 8-K and 8-K/A, our Registration Statements on Form S-3, and other SEC filings discuss some of the important risk factors that may affect Unidym’s business, results of operations and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.
For more information, please click here
Robert Bismuth, VP
Business Development & Marketing
Copyright © Business Wire 2007
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Iranian Scientists Use MOFs to Eliminate Dye Pollutants January 29th, 2015
Made-in-Singapore rapid test kit detects dengue antibodies from saliva: IBN's MedTech innovation simplifies diagnosis of infectious diseases January 29th, 2015
'Bulletproof' battery: Kevlar membrane for safer, thinner lithium rechargeables January 28th, 2015
Spider electro-combs its sticky nano-filaments January 28th, 2015
Rice's Naomi Halas to direct Smalley Institute: Optics pioneer will lead Rice's multidisciplinary science institute January 15th, 2015
SUNY Board Appoints Dr. Alain Kaloyeros as Founding President of SUNY Polytechnic Institute January 13th, 2015
Blend Therapeutics Appoints Distinguished Physician Scientist, Dennis Ausiello, MD, to Board of Directors January 8th, 2015
QD Vision Receives New Funding Round to Meet Growing Demand for Quantum Dot Technology: Industry Veteran Steve Ward Named Executive Chairman January 5th, 2015